For questions about BMS medicines during this time please call 1-800-721-8909.

ONUREG® is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.


This site is intended for U.S. healthcare professionals.


Resources for healthcare providers

Be sure to bookmark or return to this page to remember these helpful resources.

This site is best viewed in portrait mode on a smartphone or small tablet.